|
|
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy |
| 4UH3TR003271-03 |
|
NCATS |
2022 |
|
|
Optimizing Muscular Dystrophy Clinical Trial Designs using Modeling and Simulation |
| 5R21TR004006-02 |
|
NCATS |
2022 |
|
|
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening |
| 5UH3TR002151-05 |
|
NCATS |
2022 |
|
|
Neurodevelopmental Effects of Prenatal Exposure to Maternal Drinking, Smoking and Adverse Psychosocial Factors: Deep Phenotyping of Infant CNS and ANS Function |
| 1R01AA029159-01A1 |
|
NIAAA |
2022 |
|
|
The role of mitochondrial stress response in alcohol-mediated neurotoxicity |
| 1R21AA029811-01A1 |
|
NIAAA |
2022 |
|
|
Administrative Resource of the CIFASD |
| 2U24AA014811-19 |
|
NIAAA |
2022 |
|
|
Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2 |
| 4U01AA029316-02 |
|
NIAAA |
2022 |
|
|
Assessing Stable Characteristics of Endocrine Function Among Boys and Girls with Prenatal Alcohol Exposure as a Novel Clinical Tool |
| 5K01AA026889-05 |
|
NIAAA |
2022 |
|
|
Identifying and protecting alcohol-sensitive epigenetic changes in congenital heart disease |
| 5K08AA028845-02 |
|
NIAAA |
2022 |
|
|
Alcohol and pregnancy: benefits and harms of state-level policies |
| 5R01AA023267-05 |
|
NIAAA |
2022 |